Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Health › First personalised cancer vaccine cuts risk of disease...
Health

First personalised cancer vaccine cuts risk of disease returning in major trial

First personalised cancer vaccine cuts risk of disease returning in major trial
BBC News Friday 23 October 2026, 07:49 UTC 1 min read
Key Points

The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.

The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.
Originally published by BBC News Read original →

Related Stories

Africa faces 'complex' Ebola outbreak after spread to Nigeria: WHO

To display this content from YouTube, you must enable advertisement tracking and audience measurement. One of your browser extensions seems to be blocking the video player from loading. To watch this content, you may need to disable it on this site.

France 24 29m ago

Mounjaro rollout on NHS is too slow and creating ‘two-tier system’, MPs warn

Mounjaro rollout on NHS is too slow and creating ‘two-tier system’, MPs warn Only about 6 per cent of eligible patients will get Mounjaro through the NHS rollout in the first three years, says report - Bookmark - CommentsGo to comments Become an Independent member to bookmark this article Already a member? Log in NHS plans to distribute the weight-loss drug Mounjaro "are unambitious" and will reach a "woefully small number of people", MPs have warned. A report by the Commons Health and...

The Independent UK 45m ago

New test could detect men who would benefit from intensive prostate cancer treatment

New test could detect men who would benefit from intensive prostate cancer treatment - Bookmark - CommentsGo to comments Become an Independent member to bookmark this article Already a member? Log in A novel diagnostic test could enable doctors to identify prostate cancer patients in need of more aggressive care while protecting others from the side effects of redundant therapies, according to a study. The findings follow research led by University College London, which revealed that...

The Independent UK 54m ago

World first personalised cancer vaccine stops disease returning in major trial

The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.

BBC Health 1h ago